ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
CRISPR Therapeutics
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Incyte Corporation
University College, London
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Washington University School of Medicine